Top View
- Suppression of Growth, Migration and Invasion of Highly-Metastatic Human
- Absorption, Gastrointestinal, 39-43 ABT-229, 244F, 245 Abzymes, 533
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- (12) Patent Application Publication (10) Pub. No.: US 2016/0220537 A1 GARNER Et Al
- Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma
- List of Cancer Drugs (The First Batch) Ⅰ.Cancer Drugs
- Free Radical Anticancer Drugs and Oxidative Stress: ORAC and Cellrox-Colorectal Cancer Cells by Quantum Chemical Determinations Clifford Fong
- Prolonged Systemic Circulation of Chimeric Oncolytic Adenovirus Ad5/3-Cox2l-D24 in Patients with Metastatic and Refractory Solid Tumors
- Amino-Terminal Propeptide of Type III Procollagen: a New Prognosis Indicator in Human Ovarian Cancer Antti Kauppila,1 Ulla Puistola, Juha Risteli, and Leila Risteli
- Induction of Oxidative Stress by Anticancer Drugs in the Presence and Absence of Cells
- Advanced Polymer-Based Drug Delivery Systems for Chemotherapy
- Customs Tariff - Schedule Xxi - 1
- Synthesis and Antitumor Evaluation of Some 5-Fluorouracil Derivatives
- Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
- (12) United States Patent (10) Patent No.: US 7.652,009 B2 Kim Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- GRP94 Rewires and Buffers the FLT3-ITD Signaling Network And
- A Systematic Review of Drug Repurposing in Glioblastoma
- Supplementary Table 4. Description of Historical Controls (Pesonen Et Al
- Compositions for Treating Breast Cancer
- International Patent Classification
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Structural Basis for the Inhibition of SARS-Cov-2 Main Protease by Antineoplastic Drug Carmofur
- An Open Access Database of Licensed Cancer Drugs Pan Pantziarka 1,2, §, Rica Capistrano 1, Arno De Potter 3, Liese Vandeborne 1, Gauthier Bouche 1
- Free PDF Download
- Molecular Targeting of Acid Ceramidase in Glioblastoma: a Review of Its Role, Potential Treatment, and Challenges
- Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- ICD-10-CM Table of Drugs 2019
- Protargetminer: a Proteome Signature Library of Anticancer Molecules for Functional Discovery
- Postoperative Adjuvant Use of Carmofur for Early Breast Cancer
- WO 2017/035116 Al O
- Microcalorimetric Study of the Metabolism of U-937 Cells
- (12) United States Patent (10) Patent No.: US 8,318,163 B2 Appleton Et Al
- Supporting Data : the Full List of Drugs with the PAD Scores. the "Known
- Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments
- Structural Basis for the Inhibition of COVID-19 Virus Main Protease By
- Supporting Information